Literature DB >> 18725549

Genotypic distribution of hepatitis C among hepatitis C and HIV co-infected patients in Brazil.

M C Mendes-Correa1, N P Cavalheiro, C Mello, A A Barone, R J Gianini.   

Abstract

Information on hepatitis C virus (HCV) genotypic distribution among HIV-HCV co-infected patients is lacking in Brazil as well as other Latin American countries. The objective of this study was to evaluate the level of exposure to different risk factors associated with HCV transmission among a group of co-infected patients and to characterize the genotypic distribution of HCV in this cluster. A series of 100 HIV-HCV co-infected patients was analysed. The data to be analysed were collected from specific laboratory tests. Information was collected through a questionnaire. HCV genotyping was carried out by sequencing the 5' non-coding region of HCV. Chi-square and Fischer association tests or Kruskal-Wallis test were used to study the association between HCV transmission-related variables and the established genotypes. In conclusion, exposure to multiple risk factors associated with HCV transmission was common among HIV co-infected patients and an association between HCV genotype 3 and intravenous drug user was observed.

Entities:  

Mesh:

Year:  2008        PMID: 18725549     DOI: 10.1258/ijsa.2007.007183

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  1 in total

1.  HIV and HCV coinfection: prevalence, associated factors and genotype characterization in the Midwest Region of Brazil.

Authors:  Solange Zacalusni Freitas; Sheila Araújo Teles; Paulo Cesar Lorenzo; Marco Antonio Moreira Puga; Tayana Serpa Ortiz Tanaka; Danilo Yamamoto Thomaz; Regina Maria Bringel Martins; Angelita Fernandes Druzian; Andréa Siqueira Campos Lindenberg; Marina Sawada Torres; Sérgio A Pereira; Livia Melo Villar; Elisabete Lampe; Ana Rita Coimbra Motta-Castro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.